Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-09-17FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for Quinapril from BluePoint Laboratories, a generic ACE inhibitor.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy [Phase 4]
Phase 4 study evaluating the long-term efficacy of nebivolol after withdrawal of therapy in hypertension; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension [Phase 3]
Phase 3 trial comparing amlodipine plus losartan versus amlodipine alone in stage 2 hypertension has completed, evaluating efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2010-09-08Clinical Trial Update: Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients [Phase 4]
Phase 4 clinical trial evaluating the effects of continuous positive airway pressure (CPAP) and valsartan on arterial blood pressure in pati…
-
FDA approval · 2010-09-07FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension [Phase 3]
Phase 3 trial update for a triple combination therapy in hypertension with completed status and results posted.
-
FDA approval · 2010-08-31FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Moexipril hydrochloride (Teva), signaling changes to the drug's label under the ANDA process…
-
FDA approval · 2010-08-30FDA Approved: TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original application for a generic fixed-dose combination of trandolapril and verapamil hydrochloride. The product i…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: China Medical University Hospital (CMUH) Triapin Listing [Phase 4]
Phase 4 trial update showing completion of a Sanofi hypertension study for Triapin.
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Computer-Assisted Cancer Risk Behavior Counseling [Phase 1]
A Phase 1 clinical trial evaluating computer-assisted cancer risk behavior counseling sponsored by Thomas Jefferson University has been term…
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study) [Phase 4]
Phase 4 trial comparing conventional and automated office blood pressure measurements; the CAMBO study has completed.
-
FDA approval · 2010-08-20FDA Approved: CLONIDINE — Original Application (Dr. Reddy's Labratories Inc.)
FDA approved Dr. Reddy's Laboratories' clonidine as an original generic application (ANDA) for the treatment of hypertension.
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
An efficacy observational study assessing candesartan cilexetil in patients with primary hypertension has been completed.
-
FDA approval · 2010-08-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for verapamil hydrochloride from Mylan Pharmaceuticals Inc., granting/confirming approval for a …
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335) [Phase 3]
Phase 3 SAALT trial evaluated adding losartan to a reduced-sodium strategy for hypertension; results were posted after completion in 2010.
-
FDA approval · 2010-08-04FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for aliskiren hemifumarate submitted by Prasco Laboratories.
-
FDA approval · 2010-07-30FDA Approved: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Quinapril Hydrochloride/Hydrochlorothiazide from Aurobindo Pharma Limited, authorizing the marke…
-
FDA approval · 2010-07-30FDA Approved: TRANDOLAPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for trandolapril, enabling the marketing of a generic formulation. This act…
-
FDA approval · 2010-07-28FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) submitted by Mylan Institutional LLC. This action confirms ap…
-
FDA approval · 2010-07-28FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a generic combination tablet of bisoprolol fumarate and hydrochlorothiazide for hypertension, manufactured by Unichem Pharmaceu…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes [NA]
Completed clinical trial assessing the impact of computerized guidelines on the management of hypertension and diabetes.
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: Yoga for the Management of HIV-Metabolic Syndromes [Phase 4]
A Phase 4 clinical trial evaluating yoga for HIV-associated metabolic and cardiovascular conditions has completed.
-
FDA approval · 2010-07-23FDA Approved: TRIBENZOR — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' original application for Tribenzor, a triple combination antihypertensive therapy consisting of ol…
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension [Phase 4]
Phase 4 trial comparing two fixed-dose ARB/HCTZ combinations in adults with mild-to-moderate hypertension has completed, evaluating whether …
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination [Phase 4]
Phase 4 trial evaluating the efficacy and safety of the irbesartan/hydrochlorothiazide combination for hypertension has been completed.